Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Macrolide- and Telithromycin-resistant Streptococcus pyogenes, Belgium, 1999–20031
  • Published Date:
    Jun 2005
  • Source:
    Emerg Infect Dis. 11(6):939-942.
Filetype[PDF-102.26 KB]


Details:
No Related Documents.
You May Also Like:
  1. Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
    Personal Author:
    Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi;
    Published Date:
    Sep 2012
    Source:
    Emerg Infect Dis. 18(9):1515-1518.
    Description:
    In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical thresho...
    File Type:
    Filetype[PDF - 312.48 KB]
  2. Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes
    Personal Author:
    Albrich, Werner C.; Monnet, Dominique L.; Harbarth, Stephan;
    Published Date:
    Mar 2004
    Source:
    Emerg Infect Dis. 10(3):514-517.
    Description:
    We correlated outpatient antibiotic use with prevalence of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP), macrolide-resistant S. pneumoniae (MRSP), and macrolide-resistant S. pyogenes (MRGAS) in 20 countries. Total antibiotic use was corr...
    File Type:
    Filetype[PDF - 151.64 KB]
  3. Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance
    Personal Author:
    Farrell, David J.; Jenkins, Stephen G.; Brown, Steven D.; Patel, Manish; Lavin, Bruce S.; Klugman, Keith P.;
    Published Date:
    Jun 2005
    Source:
    Emerg Infect Dis. 11(6):851-858.
    Description:
    Streptococcus pneumoniae isolates (N = 31,001) were collected from patients with community-acquired respiratory tract infections during the PROTEKT US surveillance study (2000-2003). While the macrolide (erythromycin) resistance rate remained stable ...
    File Type:
    Filetype[PDF - 322.20 KB]
  4. Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
    Personal Author:
    Stratton, Charles W.
    Published Date:
    Jan 2003
    Source:
    Emerg Infect Dis. 9(1):10-16.
    Description:
    The global emergence of antibacterial resistance among common and atypical respiratory pathogens in the last decade necessitates the strategic application of antibacterial agents. The use of bactericidal rather than bacteriostatic agents as first-lin...
    File Type:
    Filetype[PDF - 221.16 KB]
  5. Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates
    Personal Author:
    Pérez-Trallero, Emilio; Marimon, José M.; Iglesias, Luis; Larruskain, Julián;
    Published Date:
    Sep 2003
    Source:
    Emerg Infect Dis. 9(9):1159-1162.
    Description:
    Streptococcus pneumoniae serotype 3, isolated from a penicillin-allergic patient and initially susceptible to fluoroquinolones, macrolides, lincosamides, quinupristin-dalfopristin, and telithromycin, became resistant to all these drugs during treatme...
    File Type:
    Filetype[PDF - 307.47 KB]